Remdesivir therapy for severe pediatric COVID‐19 in Singapore: A single‐center retrospective observational cohort study

Abstract Background and Aims There is a paucity of information on remdesivir (RDV) use in severe pediatric coronavirus disease 2019 (COVID‐19). We aimed to explore the effectiveness of RDV as the cumulative proportion of pediatric COVID‐19 patients deescalated from Day 5 of high dependency or intens...

Description complète

Détails bibliographiques

Auteurs principaux:	Valerie Xue Fen Seah, Rina Yue Ling Ong, Kai Qian Kam, Koh Cheng Thoon, Natalie Woon Hui Tan, Jiahui Li, Karen Donceras Nadua, Chia Yin Chong, Chee Fu Yung
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2023-12-01
Collection:	Health Science Reports
Sujets:	children pediatric remdesivir SARS‐CoV‐2 severe COVID‐19
Accès en ligne:	https://doi.org/10.1002/hsr2.1698
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!